“Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease”

Authors

Katherine Tuttle, ProvidenceFollow

Document Type

Presentation

Publication Date

10-1-2023

Keywords

washington; pmrc

Clinical Institute

Kidney & Diabetes

Comments

Video Journal of Biomedicine

Recommended Citation

Tuttle, Katherine, "“Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease”" (2023). Articles, Abstracts, and Reports. 8038.
https://digitalcommons.providence.org/publications/8038